1,396
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Fuzhu jiangtang granules combined with metformin reduces insulin resistance in skeletal muscle of diabetic rats via PI3K/Akt signaling

, &
Pages 660-668 | Received 01 Feb 2019, Accepted 11 Aug 2019, Published online: 23 Sep 2019

References

  • Ceddia RB. 2005. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes. 29(10):1175–1183.
  • Choi K, Kim YB. 2010. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med. 25(2):119–129.
  • Di Meo S, Iossa S, Venditti P. 2017. Skeletal muscle insulin resistance: role of mitochondria and other ROS sources. J Endocrinol. 233(1):R15–R42.
  • Guo Y, Wang L, Ma R, Mu Q, Yu N, Zhang Y, Tang Y, Li Y, Jiang G, Zhao D, et al. 2016. JiangTang XiaoKe granule attenuates cathepsin K expression and improves IGF-1 expression in the bone of high fat diet induced KK-Ay diabetic mice. Life Sci. 148:24–30.
  • He L, Wang H, Gu C, He X, Zhao L, Tong X. 2016. Administration of traditional Chinese blood circulation activating drugs for microvascular complications in patients with type 2 diabetes mellitus. J Diabetes Res. 2016:1081657.
  • Huang S, Czech MP. 2007. The GLUT4 glucose transporter. Cell Metab. 5(4):237–252.
  • Jensen CB, Martin-Gronert MS, Storgaard H, Madsbad S, Vaag A, Ozanne SE. 2008. Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight. PLoS One. 3(11):e3738.
  • Jung UJ, Choi MS. 2014. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 15(4):6184–6223.
  • Kim YB, Kotani K, Ciaraldi TP, Henry RR, Kahn BB. 2003. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction. Diabetes. 52(8):1935–1942.
  • Leto D, Saltiel AR. 2012. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 13(6):383–396.
  • Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. 2011. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metab Clin Exp. 60(1):1–23.
  • Petersen KF, Shulman GI. 2002. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol. 90(5):11–18G.
  • Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, Dhama K. 2014. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int. 2014:761264.
  • Savage DB, Petersen KF, Shulman GI. 2007. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 87(2):507–520.
  • Sun GD, Li CY, Cui WP, Guo QY, Dong CQ, Zou HB, Liu SJ, Dong WP, Miao LN. 2016. Review of herbal traditional Chinese medicine for the treatment of diabetic nephropathy. J Diabetes Res. 2016:5749857.
  • Syiem D, Warjri P. 2015. Antidiabetic, antioxidant, and TNF-α lowering properties of extract of the traditionally used plant Ixeris gracilis in alloxan-induced diabetic mice. Pharm Biol. 53(4):494–502.
  • Tong XL, Dong L, Chen L, Zhen Z. 2012. Treatment of diabetes using traditional Chinese medicine: past, present and future. Am J Chin Med. 40(5):877–886.
  • Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. 2012. Cellular and molecular mechanisms of metformin: an overview. Clin Sci. 122(6):253–270.
  • Guang-Yuan X, Wen S, Zi-Lin S, Xuan G, Li-Li W, Ling-Ling Q, Dan H, Zhuo Z, Shuo T, Xiang L, et al. 2017. Effects of heyutai fuzhu jiangtang tablets combined with metformin on insulin resistance in skeletal muscle of diabetic rats. Chinese J Information TCM. 24:39–43.
  • Yokoi N, Hoshino M, Hidaka S, Yoshida E, Beppu M, Hoshikawa R, Sudo K, Kawada A, Takagi S, Seino S. 2013. A novel rat model of type 2 diabetes: the zucker fatty diabetes mellitus ZFDM rat. J Diabetes Res. 2013:103731.
  • Yu N, Fang X, Zhao D, Mu Q, Zuo J, Ma Y, Zhang Y, Mo F, Zhang D, Jiang G, et al. 2017. Anti-diabetic effects of Jiang Tang Xiao Ke granule via PI3K/Akt Signalling Pathway in Type 2 Diabetes KKAy Mice. PLoS One. 12(1):e0168980.
  • Zdychová J, Komers R. 2005. Emerging role of akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res. 54(1):1–16.
  • Zhang Y, An H, Pan S-Y, Zhao D-D, Zuo J-C, Li X-K, Gao Y, Mu Q-Q, Yu N, Ma Y, et al. 2016. Jiang Tang Xiao Ke granule, a classic Chinese herbal formula, improves the effect of metformin on lipid and glucose metabolism in diabetic mice. Evid Based Complement Alternat Med. 2016:1592731.
  • Zhao DD, Yu N, Li XK, Fang X, Mu QQ, Qin PJ, Ma Y, Mo FF, Zhang DW, Gao SH. 2014. Antidiabetic and antioxidative effect of jiang tang xiao ke granule in high-fat diet and low-dose streptozotocin induced diabetic rats. Evid Based Complement Alternat Med. 2014:475192.